Orion Engineered Carbons S.A. Announces Third Quarter Financial Results
Orion Engineered Carbons S.A. (NYSE: OEC) reported solid third-quarter results for 2021, with net sales rising to $393.1 million, a 39.4% increase year-over-year. Net income reached $21.0 million, climbing 133.5% from last year, and basic EPS improved to $0.35. The company reinstated dividends while advancing key investments in emissions controls and Chinese expansion. Adjusted EBITDA also rose 20.8% to $66.4 million. However, the outlook indicates challenges with supply chain issues and inflation, leading to a tightened Adjusted EBITDA guidance of $265 million to $280 million.
- Net sales increased by $111.1 million or 39.4% year-over-year to $393.1 million.
- Net income rose by $12.0 million or 133.5% year-over-year to $21.0 million.
- Basic EPS climbed to $0.35, up from $0.15, an increase of $0.20.
- Adjusted EBITDA improved by $11.4 million or 20.8% year-over-year to $66.4 million.
- Dividends reinstated to enhance shareholder returns.
- Advanced key investments in U.S. emissions controls and expansion projects in China.
- Volumes in the Rubber Carbon Black segment fell by 3.0%, or 5.2 kmt.
- Adjusted EBITDA for Rubber Carbon Black decreased by $1.1 million or 4.0% year-over-year.
Third Quarter 2021 Highlights
- Reinstated dividend at a level that enhances shareholder returns without impeding continued investments aimed at driving growth in differentiated applications and raising Orion’s long-term earnings potential
- Continued strong performance in our Specialty business, despite disruptions to the global economy
-
Advanced key investments:
U.S. emissions controls,Ravenna expansion, and initiated construction of second plant inChina , positioning the company for growth from increased demand for carbon black in the rapidly expandingAsia-Pacific region -
Refinanced term debt with 7-year, sustainability-linked Term Loan B — among the first by a public corporate issuer in the
U.S. - Approximately two-thirds of 2022 EMEA and Americas Rubber business volumes contracted — at higher pricing to recover additional costs and to finance ongoing investments
-
Net sales of
, up$393.1 million , year over year$111.1 million -
Net income of
, up$21.0 million , year over year$12.0 million -
Basic EPS of
, up$0.35 , year over year$0.20 -
Adjusted EPS1 of
, up$0.45 , year over year$0.11 -
Adjusted EBITDA1 of
, up$66.4 million , year over year$11.4 million
1 The reconciliations of Non-GAAP measures to the respective most comparable GAAP measures are provided in the section titled Reconciliation of Non-GAAP Financial Measures below.
"The Orion team delivered a solid third quarter—in line with our expectations, with Adjusted EBITDA up
Third Quarter 2021 Overview:
(In millions, except per share data or stated otherwise) |
|
Q3 2021 |
|
Q3 2020 |
|
Y/Y Change |
|
Y/Y Change in % |
Volume (kmt) |
|
236.9 |
|
237.0 |
|
(0.1) |
|
(0.1)% |
Net sales |
|
393.1 |
|
282.0 |
|
111.1 |
|
|
Income from operations |
|
40.3 |
|
24.1 |
|
16.2 |
|
|
Net income |
|
21.0 |
|
9.0 |
|
12.0 |
|
|
Contribution margin |
|
140.5 |
|
118.2 |
|
22.3 |
|
|
Contribution margin per metric ton |
|
593.1 |
|
498.6 |
|
94.5 |
|
|
Adjusted EBITDA (1) |
|
66.4 |
|
55.0 |
|
11.4 |
|
|
Basic EPS |
|
0.35 |
|
0.15 |
|
0.20 |
|
|
Diluted EPS |
|
0.35 |
|
0.15 |
|
0.20 |
|
|
Adjusted EPS(1) |
|
0.45 |
|
0.34 |
|
0.11 |
|
0.32 |
(1) |
The reconciliations of these non-GAAP measures to the respective most comparable GAAP measures are provided in the section titled Reconciliation of Non-GAAP Financial Measures. |
Volumes decreased by 0.1 kmt, year over year, primarily due to lower volume in the Rubber Carbon Black segment, partially offset by higher demand in our Specialty Carbon Black segment, across all applications and geographies, primarily driven by global recovery from the COVID-19 induced economic downturn.
Net sales increased by
Income from operations increased by
Net income increased by
Contribution margin increased by
Adjusted EBITDA increased by
Quarterly Business Segment Results
SPECIALTY |
||||||||
(In millions, unless stated otherwise) |
|
Q3 2021 |
|
Q3 2020 |
|
Y/Y Change |
|
Y/Y Change in % |
Volume (kmt) |
|
63.9 |
|
58.8 |
|
5.1 |
|
|
Net sales |
|
150.2 |
|
103.6 |
|
46.6 |
|
|
Gross profit |
|
51.6 |
|
37.1 |
|
14.5 |
|
|
Gross profit per metric ton |
|
807.5 |
|
631.6 |
|
175.9 |
|
|
Adjusted EBITDA |
|
39.0 |
|
26.5 |
|
12.5 |
|
|
Adjusted EBITDA/metric ton |
|
610.7 |
|
450.5 |
|
160.2 |
|
|
Adjusted EBITDA Margin (%) |
|
|
|
|
|
50bps |
|
|
Net sales rose by
Specialty Adjusted EBITDA rose by
RUBBER |
||||||||
(In millions, unless stated otherwise) |
|
Q3 2021 |
|
Q3 2020 |
|
Y/Y Change |
|
Y/Y Change in % |
Volume (kmt) |
|
173.0 |
|
178.2 |
|
(5.2) |
|
(3.0)% |
Net sales |
|
242.9 |
|
178.4 |
|
64.5 |
|
|
Gross profit |
|
47.1 |
|
42.1 |
|
5.0 |
|
|
Gross profit per metric ton |
|
281.6 |
|
236.0 |
|
45.6 |
|
|
Adjusted EBITDA |
|
27.4 |
|
28.5 |
|
(1.1) |
|
(4.0)% |
Adjusted EBITDA/metric ton |
|
158.4 |
|
160.0 |
|
(1.6) |
|
|
Adjusted EBITDA Margin (%) |
|
|
|
|
|
(470)bps |
|
(29.5)% |
Rubber
Net sales increased by
Rubber Adjusted EBITDA declined by
Balance Sheet and Cash Flows
As of
Cash Flow
Cash inflows from operating activities amounted to
Net cash used in investing activities was
Net cash used in financing activities of
Outlook
"As we approach the end of an exceptional year, we are narrowing our Adjusted EBITDA guidance to a range of
Conference Call
As previously announced, Orion will hold a conference call tomorrow,
|
|
1-877-407-4018 |
|
|
|||
International: |
|
1-201-689-8471 |
|
|
A replay of the conference call may be accessed by phone at the following numbers through
|
|
1-844-512-2921 |
|
|
|||
International: |
|
1-412-317-6671 |
|
|
|||
Conference ID: |
|
13723520 |
|
|
Additionally, an archived webcast of the conference call will be available on the Investor Relations section of the company’s website at www.orioncarbons.com.
To learn more about Orion, visit the company’s website at www.orioncarbons.com, where we regularly post information including notification of events, news, financial performance, investor presentations and webcasts, non-GAAP reconciliations,
About
Forward-Looking Statements
This document contains and refers to certain forward-looking statements with respect to our financial condition, results of operations and business, including those in the “Outlook” and “Quarterly Business Segment Results” sections above. These statements constitute forward-looking statements within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). Forward-looking statements are statements of future expectations that are based on management’s current expectations and assumptions and involve known and unknown risks and uncertainties that could cause actual results, performance or events to differ materially from those expressed or implied in these statements. Forward-looking statements include, among others, statements concerning the potential exposure to market risks, statements expressing management’s expectations, beliefs, estimates, forecasts, projections and assumptions and statements that are not limited to statements of historical or present facts or conditions. Forward-looking statements are typically identified by words such as “anticipate,” "assume," “assure,” “believe,” “confident,” “could,” “estimate,” “expect,” “intend,” “may,” “plan,” “objectives,” “outlook,” “probably,” “project,” “will,” “seek,” “target” “to be,” and other words of similar meaning.
These forward-looking statements include, without limitation, statements about the following matters: • our strategies for (i) mitigating the impacts of the global outbreak of the Coronavirus, (ii) strengthening our position in specialty carbon blacks and rubber carbon blacks, (iii) increasing our rubber carbon black margins and (iv) strengthening the competitiveness of our operations; • the ability to pay dividends at historical dividend levels or at all; • cash flow projections; • the installation of pollution control technology in our
All these forward-looking statements are based on estimates and assumptions that, although believed to be reasonable, are inherently uncertain. Therefore, undue reliance should not be placed upon any forward-looking statements. There are important factors that could cause actual results to differ materially from those contemplated by such forward-looking statements. These factors include, among others: • the effects of the COVID-19 pandemic on our business and results of operations; • negative or uncertain worldwide economic conditions; • volatility and cyclicality in the industries in which we operate; • operational risks inherent in chemicals manufacturing, including disruptions as a result of severe weather conditions and natural disasters; • our dependence on major customers and suppliers; • our ability to compete in the industries and markets in which we operate; • our ability to address changes in the nature of future transportation and mobility concepts which may impact our customers and our business; • our ability to develop new products and technologies successfully and the availability of substitutes for our products; • our ability to implement our business strategies; • volatility in the costs and availability of raw materials and energy; • our ability to respond to changes in feedstock prices and quality; • our ability to realize benefits from investments, joint ventures, acquisitions or alliances; • our ability to realize benefits from planned plant capacity expansions and site development projects and the potential delays to such expansions and projects; • information technology systems failures, network disruptions and breaches of data security; • our relationships with our workforce, including negotiations with labor unions, strikes and work stoppages; • our ability to recruit or retain key management and personnel; • our exposure to political or country risks inherent in doing business in some countries; • geopolitical events in the
You should not place undue reliance on forward-looking statements. We present certain financial measures that are not prepared in accordance with
Factors that could cause our actual results to differ materially from those expressed or implied in such forward-looking statements include those factors detailed under the captions “Note Regarding Forward-Looking Statements” and “Risk Factors” in our Annual Report on Form 10-K for the year ended
Reconciliation of Non-GAAP Financial Measures
We present certain financial measures that are not prepared in accordance with
We use Adjusted EBITDA,
Different companies and analysts may calculate measures based on EBITDA, contribution margins and working capital differently, so making comparisons among companies on this basis should be done carefully. Adjusted EBITDA,
Reconciliation of Non-GAAP to GAAP Financial Measures
The following tables present a reconciliation of each of Adjusted EBITDA and Adjusted EPS to the most directly comparable GAAP measure:
Reconciliation of profit |
Third Quarter |
|
Nine Months Ended |
||||||||||||||||
(In thousands) |
2021 |
|
2020 |
|
2021 |
|
2020 |
||||||||||||
|
|
||||||||||||||||||
Net income |
$ |
21,012 |
|
|
|
$ |
8,997 |
|
|
|
$ |
133,608 |
|
|
|
$ |
9,250 |
|
|
Add back income tax expense |
6,753 |
|
|
|
2,250 |
|
|
|
48,517 |
|
|
|
4,006 |
|
|
||||
Add back equity in earnings of affiliated companies, net of tax |
(143 |
) |
|
|
(141 |
) |
|
|
(536 |
) |
|
|
(426 |
) |
|
||||
Income before earnings in affiliated companies and income taxes |
27,622 |
|
|
|
11,106 |
|
|
|
181,589 |
|
|
|
12,830 |
|
|
||||
Add back interest and other financial expense, net |
11,456 |
|
|
|
10,768 |
|
|
|
30,366 |
|
|
|
28,656 |
|
|
||||
Add back reclassification of actuarial losses from AOCI |
1,197 |
|
|
|
2,273 |
|
|
|
3,649 |
|
|
|
7,325 |
|
|
||||
Income from operations |
40,275 |
|
|
|
24,147 |
|
|
|
215,604 |
|
|
|
48,811 |
|
|
||||
Add back depreciation and amortization of intangible assets, right of use assets, and property, plant and equipment |
23,810 |
|
|
|
23,999 |
|
|
|
74,610 |
|
|
|
69,721 |
|
|
||||
EBITDA |
64,085 |
|
|
|
48,146 |
|
|
|
290,214 |
|
|
|
118,532 |
|
|
||||
Equity in earnings of affiliated companies, net of tax |
143 |
|
|
|
141 |
|
|
|
536 |
|
|
|
426 |
|
|
||||
Evonik legal settlement: |
|
|
|
|
|
|
|
||||||||||||
Cash settlement |
— |
|
|
|
— |
|
|
|
(79,499 |
) |
|
|
— |
|
|
||||
Release of legal reserve, net |
— |
|
|
|
— |
|
|
|
(3,359 |
) |
|
|
— |
|
|
||||
Long term incentive plan |
1,120 |
|
|
|
1,182 |
|
|
|
3,396 |
|
|
|
1,242 |
|
|
||||
EPA-related expenses |
82 |
|
|
|
1,487 |
|
|
|
2,282 |
|
|
|
5,053 |
|
|
||||
Extraordinary expense items related to COVID-19 |
— |
|
|
|
823 |
|
|
|
— |
|
|
|
3,548 |
|
|
||||
Other adjustments |
986 |
|
|
|
3,223 |
|
|
|
2,512 |
|
|
|
5,283 |
|
|
||||
Adjusted EBITDA |
$ |
66,416 |
|
|
|
$ |
55,002 |
|
|
|
$ |
216,082 |
|
|
|
$ |
134,084 |
|
|
The following table reconciles Contribution Margin and Contribution Margin per Metric Ton to gross profit:
|
Third Quarter |
|
Nine Months Ended |
||||||||||||||||
(In millions, unless otherwise indicated) |
2021 |
|
2020 |
|
2021 |
|
2020 |
||||||||||||
|
|
||||||||||||||||||
Net sales |
$ |
393.1 |
|
|
|
$ |
282.0 |
|
|
|
$ |
1,154.1 |
|
|
|
$ |
820.7 |
|
|
Variable costs |
252.6 |
|
|
|
163.8 |
|
|
|
712.9 |
|
|
|
496.4 |
|
|
||||
Contribution Margin |
140.5 |
|
|
|
118.2 |
|
|
|
441.2 |
|
|
|
324.3 |
|
|
||||
Freight |
23.3 |
|
|
|
17.9 |
|
|
|
69.8 |
|
|
|
48.7 |
|
|
||||
Fixed costs |
(65.1 |
) |
|
|
(56.9 |
) |
|
|
(199.7 |
) |
|
|
(169.7 |
) |
|
||||
Gross profit |
$ |
98.7 |
|
|
|
$ |
79.2 |
|
|
|
$ |
311.3 |
|
|
|
$ |
203.3 |
|
|
Volume (in kmt) |
236.9 |
|
|
|
237.0 |
|
|
|
741.2 |
|
|
|
629.1 |
|
|
||||
Contribution margin per metric ton |
$ |
593.1 |
|
|
|
$ |
498.6 |
|
|
|
$ |
595.3 |
|
|
|
$ |
515.6 |
|
|
Gross profit per metric ton |
$ |
416.8 |
|
|
|
$ |
334.1 |
|
|
|
$ |
420.0 |
|
|
|
$ |
323.2 |
|
|
Adjusted EPS |
Third Quarter |
|
Nine Months Ended |
||||||||||||||||
(In thousands, except per share amounts) |
2021 |
|
2020 |
|
2021 |
|
2020 |
||||||||||||
|
|
||||||||||||||||||
Net income |
$ |
21,012 |
|
|
|
$ |
8,997 |
|
|
|
$ |
133,608 |
|
|
|
$ |
9,250 |
|
|
add back long term incentive plan |
1,120 |
|
|
|
1,182 |
|
|
|
3,396 |
|
|
|
1,242 |
|
|
||||
add back EPA-related expenses |
82 |
|
|
|
1,487 |
|
|
|
2,282 |
|
|
|
5,053 |
|
|
||||
add back extraordinary expense items related COVID-19 |
— |
|
|
|
823 |
|
|
|
— |
|
|
|
3,548 |
|
|
||||
add back other adjustment items |
986 |
|
|
|
3,223 |
|
|
|
2,512 |
|
|
|
5,283 |
|
|
||||
add back reclassification of actuarial losses from AOCI |
1,197 |
|
|
|
2,273 |
|
|
|
3,649 |
|
|
|
7,325 |
|
|
||||
add back amortization |
1,974 |
|
|
|
1,958 |
|
|
|
6,011 |
|
|
|
5,646 |
|
|
||||
less gain related to legal settlement |
— |
|
|
|
— |
|
|
|
(82,858 |
) |
|
|
— |
|
|
||||
add back foreign exchange rate impacts |
757 |
|
|
|
5,072 |
|
|
|
5,243 |
|
|
|
12,380 |
|
|
||||
add back amortization of transaction costs |
2,680 |
|
|
|
530 |
|
|
|
3,756 |
|
|
|
1,531 |
|
|
||||
Tax effect on add back items at estimated tax rate |
(2,639 |
) |
|
|
(4,964 |
) |
|
|
16,803 |
|
|
|
(12,601 |
) |
|
||||
Adjusted net income |
$ |
27,169 |
|
|
|
$ |
20,581 |
|
|
|
$ |
94,402 |
|
|
|
$ |
38,657 |
|
|
|
|
|
|
|
|
|
|
||||||||||||
Total add back items |
$ |
6,157 |
|
|
|
$ |
11,584 |
|
|
|
$ |
(39,206 |
) |
|
|
$ |
29,407 |
|
|
Impact add back items per share |
$ |
0.10 |
|
|
|
$ |
0.19 |
|
|
|
$ |
(0.64 |
) |
|
|
$ |
0.49 |
|
|
Earnings per share (basic) |
$ |
0.35 |
|
|
|
$ |
0.15 |
|
|
|
$ |
2.20 |
|
|
|
$ |
0.15 |
|
|
Adjusted EPS |
$ |
0.45 |
|
|
|
$ |
0.34 |
|
|
|
$ |
1.56 |
|
|
|
$ |
0.64 |
|
|
Condensed Consolidated Statements of Operations (Unaudited) |
|||||||||||||||||
|
Three Months Ended |
|
Nine Months Ended |
||||||||||||||
(In thousands, except per share amounts) |
2021 |
|
2020 |
|
2021 |
|
2020 |
||||||||||
|
|
||||||||||||||||
Net sales |
$ |
393,066 |
|
|
|
$ |
282,036 |
|
|
$ |
1,154,119 |
|
|
|
$ |
820,691 |
|
Cost of sales |
294,345 |
|
|
|
202,854 |
|
|
842,801 |
|
|
|
617,372 |
|
||||
Gross profit |
98,721 |
|
|
|
79,182 |
|
|
311,318 |
|
|
|
203,319 |
|
||||
Selling, general and administrative expenses |
52,872 |
|
|
|
43,155 |
|
|
160,289 |
|
|
|
126,221 |
|
||||
Research and development costs |
5,677 |
|
|
|
7,352 |
|
|
16,379 |
|
|
|
16,757 |
|
||||
Gain related to litigation settlement |
— |
|
|
|
— |
|
|
(82,858 |
) |
|
|
— |
|
||||
Other (income) expenses, net |
(103 |
) |
|
|
4,528 |
|
|
1,904 |
|
|
|
11,530 |
|
||||
Income from operations |
40,275 |
|
|
|
24,147 |
|
|
215,604 |
|
|
|
48,811 |
|
||||
Interest and other financial expense, net |
11,456 |
|
|
|
10,768 |
|
|
30,366 |
|
|
|
28,656 |
|
||||
Reclassification of actuarial losses from AOCI |
1,197 |
|
|
|
2,273 |
|
|
3,649 |
|
|
|
7,325 |
|
||||
Income before earnings in affiliated companies and income taxes |
27,622 |
|
|
|
11,106 |
|
|
181,589 |
|
|
|
12,830 |
|
||||
|
|
|
|
|
|
|
|
||||||||||
Income tax expense |
6,753 |
|
|
|
2,250 |
|
|
48,517 |
|
|
|
4,006 |
|
||||
Equity in earnings of affiliated companies, net of tax |
143 |
|
|
|
141 |
|
|
536 |
|
|
|
426 |
|
||||
Net income |
$ |
21,012 |
|
|
|
$ |
8,997 |
|
|
$ |
133,608 |
|
|
|
$ |
9,250 |
|
|
|
|
|
|
|
|
|
||||||||||
Weighted-average shares outstanding: |
|
|
|
|
|
|
|
||||||||||
Basic |
60,740 |
|
|
|
60,487 |
|
|
60,680 |
|
|
|
60,408 |
|
||||
Diluted |
60,840 |
|
|
|
61,259 |
|
|
60,756 |
|
|
|
61,296 |
|
||||
Earnings per share: |
|
|
|
|
|
|
|
||||||||||
Basic |
$ |
0.35 |
|
|
|
$ |
0.15 |
|
|
$ |
2.20 |
|
|
|
$ |
0.15 |
|
Diluted |
$ |
0.35 |
|
|
|
$ |
0.15 |
|
|
$ |
2.20 |
|
|
|
$ |
0.15 |
|
Condensed Consolidated Statements of Financial Position (Unaudited) |
||||||||||
(In thousands, except share amounts) |
|
|
|
|
||||||
|
|
|
||||||||
ASSETS |
|
|
|
|
||||||
Current assets |
|
|
|
|
||||||
Cash and cash equivalents |
|
$ |
62,334 |
|
|
|
$ |
64,869 |
|
|
Accounts receivable, net |
|
300,697 |
|
|
|
234,796 |
|
|
||
Other current financial assets |
|
2,958 |
|
|
|
3,630 |
|
|
||
Inventories, net |
|
192,898 |
|
|
|
141,461 |
|
|
||
Income tax receivables |
|
9,946 |
|
|
|
11,249 |
|
|
||
Prepaid expenses and other current assets |
|
38,065 |
|
|
|
44,451 |
|
|
||
Total current assets |
|
606,898 |
|
|
|
500,456 |
|
|
||
Property, plant and equipment, net |
|
655,185 |
|
|
|
610,530 |
|
|
||
Right-of-use assets |
|
90,516 |
|
|
|
85,639 |
|
|
||
|
|
79,716 |
|
|
|
84,480 |
|
|
||
Intangible assets, net |
|
38,794 |
|
|
|
46,772 |
|
|
||
Investment in equity method affiliates |
|
5,252 |
|
|
|
5,637 |
|
|
||
Deferred income tax assets |
|
59,317 |
|
|
|
52,563 |
|
|
||
Other financial assets |
|
712 |
|
|
|
761 |
|
|
||
Other assets |
|
2,536 |
|
|
|
2,955 |
|
|
||
Total non-current assets |
|
932,028 |
|
|
|
889,337 |
|
|
||
Total assets |
|
$ |
1,538,926 |
|
|
|
$ |
1,389,793 |
|
|
|
|
|
|
|
||||||
LIABILITIES AND STOCKHOLDERS' EQUITY |
|
|
|
|
||||||
Current liabilities |
|
|
|
|
||||||
Accounts payable |
|
$ |
150,152 |
|
|
|
$ |
131,250 |
|
|
Current portion of long term debt and other financial liabilities |
|
70,597 |
|
|
|
82,618 |
|
|
||
Current portion of employee benefit plan obligation |
|
1,055 |
|
|
|
1,118 |
|
|
||
Accrued liabilities |
|
49,662 |
|
|
|
49,176 |
|
|
||
Income taxes payable |
|
51,559 |
|
|
|
23,906 |
|
|
||
Other current liabilities |
|
41,210 |
|
|
|
36,677 |
|
|
||
Total current liabilities |
|
364,235 |
|
|
|
324,745 |
|
|
||
Long-term debt, net |
|
639,270 |
|
|
|
655,826 |
|
|
||
Employee benefit plan obligation |
|
78,968 |
|
|
|
83,310 |
|
|
||
Deferred income tax liabilities |
|
44,889 |
|
|
|
38,770 |
|
|
||
Other liabilities |
|
98,818 |
|
|
|
106,129 |
|
|
||
Total non-current liabilities |
|
861,945 |
|
|
|
884,035 |
|
|
||
Stockholders' Equity |
|
|
|
|
||||||
Common stock |
|
|
|
|
||||||
Authorized: 65,035,579 and 65,035,579 shares with no par value |
|
|
|
|
||||||
Issued – 60,992,259 and 60,992,259 shares with no par value |
|
|
|
|
||||||
Outstanding – 60,633,302 and 60,487,117 shares |
|
85,323 |
|
|
|
85,323 |
|
|
||
|
|
(6,546 |
) |
|
|
(8,515 |
) |
|
||
Additional paid-in capital |
|
69,893 |
|
|
|
68,502 |
|
|
||
Retained earnings |
|
218,015 |
|
|
|
84,407 |
|
|
||
Accumulated other comprehensive loss |
|
(53,939 |
) |
|
|
(48,704 |
) |
|
||
Total stockholders' equity |
|
312,746 |
|
|
|
181,013 |
|
|
||
Total liabilities and stockholders' equity |
|
$ |
1,538,926 |
|
|
|
$ |
1,389,793 |
|
|
Condensed Consolidated Statements of Cash Flows (Unaudited) |
||||||||||
|
|
Nine Months Ended |
||||||||
(In thousands) |
|
2021 |
|
2020 |
||||||
|
|
|||||||||
Cash flows from operating activities: |
|
|
|
|
||||||
Net income |
|
$ |
133,608 |
|
|
|
$ |
9,250 |
|
|
Adjustments to reconcile net income to net cash provided by (used in) operating activities: |
|
|
|
|
||||||
Depreciation of property, plant and equipment and amortization of intangible assets and right of use assets |
|
74,610 |
|
|
|
69,721 |
|
|
||
Amortization of debt issuance costs |
|
3,756 |
|
|
|
1,531 |
|
|
||
Share-based incentive compensation |
|
3,396 |
|
|
|
1,242 |
|
|
||
Deferred tax (benefit) |
|
(2,693 |
) |
|
|
(11,224 |
) |
|
||
Foreign currency transactions |
|
(8,979 |
) |
|
|
(1,782 |
) |
|
||
Reclassification of actuarial losses from AOCI |
|
3,649 |
|
|
|
7,325 |
|
|
||
Other operating non-cash items, net |
|
(2,436 |
) |
|
|
118 |
|
|
||
Changes in operating assets and liabilities, net: |
|
|
|
|
||||||
Trade receivables |
|
(75,696 |
) |
|
|
(6,682 |
) |
|
||
Inventories |
|
(57,967 |
) |
|
|
39,576 |
|
|
||
Trade payables |
|
12,584 |
|
|
|
(31,662 |
) |
|
||
Other provisions |
|
6,519 |
|
|
|
(4,899 |
) |
|
||
Income tax liabilities |
|
30,861 |
|
|
|
16,298 |
|
|
||
Other assets and liabilities, net |
|
57 |
|
|
|
3,540 |
|
|
||
Net cash provided by operating activities |
|
121,269 |
|
|
|
92,352 |
|
|
||
Cash flows from investing activities: |
|
|
|
|
||||||
Acquisition of property, plant and equipment |
|
(113,682 |
) |
|
|
(120,343 |
) |
|
||
Net cash used in investing activities |
|
(113,682 |
) |
|
|
(120,343 |
) |
|
||
Cash flows from financing activities: |
|
|
|
|
||||||
Proceeds from long-term debt borrowings |
|
213,427 |
|
|
|
— |
|
|
||
Repayments of long-term debt |
|
(212,250 |
) |
|
|
(6,077 |
) |
|
||
Payments for debt issue costs |
|
(2,750 |
) |
|
|
— |
|
|
||
Cash inflows related to current financial liabilities |
|
81,367 |
|
|
|
191,041 |
|
|
||
Cash outflows related to current financial liabilities |
|
(87,345 |
) |
|
|
(110,859 |
) |
|
||
Dividends paid to shareholders |
|
— |
|
|
|
(12,045 |
) |
|
||
Taxes paid for shares issued under net settlement feature |
|
(36 |
) |
|
|
(1,202 |
) |
|
||
Net cash provided by (used in) financing activities |
|
(7,587 |
) |
|
|
60,858 |
|
|
||
Increase in cash, cash equivalents and restricted cash |
|
— |
|
|
|
32,867 |
|
|
||
Cash, cash equivalents and restricted cash at the beginning of the period |
|
67,865 |
|
|
|
68,231 |
|
|
||
Effect of exchange rate changes on cash |
|
(2,703 |
) |
|
|
(703 |
) |
|
||
Cash, cash equivalents and restricted cash at the end of the period |
|
65,162 |
|
|
|
100,395 |
|
|
||
Less restricted cash at the end of the period |
|
2,828 |
|
|
|
2,859 |
|
|
||
Cash and cash equivalents at the end of the period |
|
$ |
62,334 |
|
|
|
$ |
97,536 |
|
|
|
|
|
|
|
View source version on businesswire.com: https://www.businesswire.com/news/home/20211104006039/en/
INVESTOR CONTACT:
Investor Relations
+1 281-974-0155
Source:
FAQ
What are Orion's Q3 2021 financial results?
How much did Orion's net income increase in Q3 2021?
What is Orion's Adjusted EBITDA guidance for 2021?
What were the major factors impacting Orion's Q3 2021 performance?